These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8196866)

  • 1. Influenza vaccination coverage in old people's homes in central Auckland.
    Calder L
    N Z Med J; 1994 May; 107(978):202. PubMed ID: 8196866
    [No Abstract]   [Full Text] [Related]  

  • 2. Practices and policies for influenza immunization in old people's homes in Nottingham (UK) during the 1992-1993 season: potential for improvement.
    Warren SS; Nguyen-Van-Tam JS; Pearson JC; Madeley RJ
    J Public Health Med; 1995 Dec; 17(4):392-6. PubMed ID: 8639337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza vaccination coverage in Canterbury rest homes.
    Weir R; Jennings L; Brunton C
    N Z Med J; 2000 Nov; 113(1122):503-5. PubMed ID: 11198545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons.
    Blank PR; Schwenkglenks M; Szucs TD
    J Infect; 2009 Jun; 58(6):446-58. PubMed ID: 19446340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccination among New Zealand healthcare workers: low rates are concerning.
    Jennings L
    N Z Med J; 2006 May; 119(1233):U1961. PubMed ID: 16680177
    [No Abstract]   [Full Text] [Related]  

  • 6. Influenza vaccination among the elderly Spanish population: trend from 1993 to 2003 and vaccination-related factors.
    de Andres AL; Garrido PC; Hernández-Barrera V; Del Pozo SV; de Miguel AG; Jiménez-García R
    Eur J Public Health; 2007 Jun; 17(3):272-7. PubMed ID: 17071634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised intervention study to examine the effect on immunisation coverage of making influenza vaccine available at no cost.
    Satterthwaite P
    N Z Med J; 1997 Feb; 110(1038):58-60. PubMed ID: 9076288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifesaving opportunities missed: the challenge of vaccinating older Americans for pneumococcal diseases and influenza.
    Tschantz K; Foley LA
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2000 Oct; (IB45):1-9. PubMed ID: 11885591
    [No Abstract]   [Full Text] [Related]  

  • 9. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coverages and factors associated with influenza vaccination among subjects with chronic respiratory diseases in Spain.
    López-de-Andrés A; Carrasco-Garrido P; Hernández-Barrera V; de Miguel AG; Jiménez-García R
    Eur J Public Health; 2008 Apr; 18(2):173-7. PubMed ID: 17875577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring county-level vaccination coverage during the 2004-2005 influenza season.
    Jia H; Link M; Holt J; Mokdad AH; Li L; Levy PS
    Am J Prev Med; 2006 Oct; 31(4):275-280. PubMed ID: 16979450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza and pneumococcal vaccination coverage among persons aged > or =65 years and persons aged 18-64 years with diabetes or asthma--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Nov; 53(43):1007-12. PubMed ID: 15525897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost-effectiveness of prophylaxis and treatment of influenza].
    Rychlik R; Heinen-Kammerer T; Rusche H; Piercy J; Scuffham P; Zöllner Y
    Dtsch Med Wochenschr; 2003 Oct; 128(43):2267-70. PubMed ID: 14574642
    [No Abstract]   [Full Text] [Related]  

  • 14. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
    Newall AT; Scuffham PA; Kelly H; Harsley S; Macintyre CR
    Vaccine; 2008 Apr; 26(17):2142-53. PubMed ID: 18343537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons.
    Szucs TD; Müller D
    Vaccine; 2005 Oct; 23(43):5055-63. PubMed ID: 16046035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of influenza vaccination of nursing home staff on mortality of residents: a cluster-randomized trial.
    Lemaitre M; Meret T; Rothan-Tondeur M; Belmin J; Lejonc JL; Luquel L; Piette F; Salom M; Verny M; Vetel JM; Veyssier P; Carrat F
    J Am Geriatr Soc; 2009 Sep; 57(9):1580-6. PubMed ID: 19682118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine cost-effective, but underused.
    Nurs Manage; 2002 Oct; 33(10):10. PubMed ID: 12408137
    [No Abstract]   [Full Text] [Related]  

  • 18. Could a federal program to promote influenza vaccination among elders be cost-effective?
    Patel MS; Davis MM
    Prev Med; 2006 Mar; 42(3):240-6. PubMed ID: 16480761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Targets groups for influenza vaccinations will be revised].
    Pyhälä R
    Duodecim; 2002; 118(1):73-4. PubMed ID: 12229001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.